164 related articles for article (PubMed ID: 37365416)
1. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
Kobayashi K; Ono Y; Kitano Y; Oba A; Sato T; Ito H; Mise Y; Shinozaki E; Inoue Y; Yamaguchi K; Saiura A; Takahashi Y
Ann Surg Oncol; 2023 Nov; 30(12):7338-7347. PubMed ID: 37365416
[TBL] [Abstract][Full Text] [Related]
2. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
3. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
4. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
Adam R; Bhangui P; Poston G; Mirza D; Nuzzo G; Barroso E; Ijzermans J; Hubert C; Ruers T; Capussotti L; Ouellet JF; Laurent C; Cugat E; Colombo PE; Milicevic M
Ann Surg; 2010 Nov; 252(5):774-87. PubMed ID: 21037433
[TBL] [Abstract][Full Text] [Related]
5. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.
Kitano Y; Ono Y; Kobayashi K; Oba A; Sato T; Ito H; Inoue Y; Shinozaki E; Yamaguchi K; Saiura A; Baba H; Takahashi Y
HPB (Oxford); 2024 Feb; 26(2):282-290. PubMed ID: 37985325
[TBL] [Abstract][Full Text] [Related]
7. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
[TBL] [Abstract][Full Text] [Related]
8. Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.
de Haas RJ; Wicherts DA; Flores E; Ducreux M; Lévi F; Paule B; Azoulay D; Castaing D; Lemoine A; Adam R
Ann Surg Oncol; 2010 Apr; 17(4):1010-23. PubMed ID: 20052553
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
11. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
[TBL] [Abstract][Full Text] [Related]
12. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
14. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.
Ushida Y; Inoue Y; Ito H; Oba A; Mise Y; Ono Y; Sato T; Saiura A; Takahashi Y
Pancreatology; 2021 Jan; 21(1):130-137. PubMed ID: 33303373
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for nonresectable liver metastases from colorectal cancer.
Hagness M; Foss A; Line PD; Scholz T; Jørgensen PF; Fosby B; Boberg KM; Mathisen O; Gladhaug IP; Egge TS; Solberg S; Hausken J; Dueland S
Ann Surg; 2013 May; 257(5):800-6. PubMed ID: 23360920
[TBL] [Abstract][Full Text] [Related]
16. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
[TBL] [Abstract][Full Text] [Related]
18. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
[TBL] [Abstract][Full Text] [Related]
19. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
[TBL] [Abstract][Full Text] [Related]
20. Multicentre study of perioperative
Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
